Skip to content

Managing Chronic Pain in Veterans With Substance Use Disorders

CompletedEarly phase 1NCT00982410
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The proposed project will provide crucial data on the effectiveness of a pain management intervention designed for veterans with co-occurring pain and substance use disorders. The development of an empirically validated psychosocial intervention for managing pain and substance misuse could greatly enhance the current set of options for treating this large and understudied group of veterans.

Study details

Official title
Managing Chronic Pain in Veterans With Substance Use Disorders
Conditions
Interventions
  • Behavioral: cognitive-behavioral treatment
  • Behavioral: educational supportive group
Sponsor
US Department of Veterans Affairs
Organization
VA Office of Research and Development
Start date
2010-04
Primary completion
2013-08
Sex
All
Age range
from 18 Years
Results posted
Yes, on ClinicalTrials.gov
Countries
United States
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * A report of pain of at least moderate or greater over the three months prior to baseline assessment as indicated by an average score of four or greater on the Numeric Rating Scale of pain intensity (NRS-I; Farrar et al. 2001); * Completion of an intake assessment in the Ann Arbor VA's SUD clinic within the three months prior to baseline assessment. The pain-related inclusion criterion will be used to ensure that participants are experiencing elevated levels of pain and, consequently, are appropriate for pain-related treatment. Exclusion Criteria: * Acute suicidality based on responses on the Beck Depression Inventory (BDI) confirmed by in-depth assessment of patient by the research associate; * Psychiatric condition that precludes participation in outpatient group treatment based on: * a Mini-Mental State Examination (MMSE; Folstein et al. 1975) score less than 21, * psychiatric hospitalization within the past month, or * endorsement of current psychotic symptoms on the Brief Symptom Inventory (BSI; Derogatis 1993) combined with noticeable bizarre thoughts or behavior during the interview; * Inability to speak and understand English; and * The inability to give informed, voluntary, written consent. Decisions about exclusion criteria 1 and 2 will be made using a combination of self-reported symptoms and researcher's judgment.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT00982410